Repligen Corp (NASDAQ:RGEN) - Share price - Overview


Stock Report

Repligen Corp RGEN

Last Price
$54.20

Day Change
-1.12|-2.02%

As of 17/04/2019
16:12:56 EDT | USD
Minimum 15 Minutes Delay.

Last Close55.32
Day Range53.39 - 55.59
Mkt Cap2.38Bil
52-Wk Range36.41 - 70.50
Yield %-
ISINUS7599161095
Volume287,510
P/E146.49
P/S12.71
P/CF75.20

Share Price

Financials
201620172018
More ...
Income Statement
Revenue104.54141.24194.03
Operating Income19.2214.0125.99
Net Income11.6828.3516.62
Basic EPS0.350.740.38
Avg. Diluted Shares Outstanding343945
Balance Sheet
Current Assets184.15242.78275.74
Non Current Assets104.76500.74498.88
Total Assets288.91743.52774.62
Current Liabilities21.0825.21129.84
Total Liabilities120.15151.97159.05
Total Equity168.76591.55615.57
Cash Flow
Operating Cash Flow7.5217.4532.77
Capital Expenditure-4.33-5.45-14.04
Free Cash Flow3.2012.0018.73

In millions, except "Basic EPS". Currency is USD.

Company Profile

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

548
Key Stats
More ...
Price/Earning TTM145.58
Price/Book3.95
Price/Sales TTM12.96
Rev Growth (3 year avg)32.43
EPS Growth (3 year avg)-
Operating Margin % TTM13.39
Net Margin % TTM8.56
ROE TTM2.75
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.